We studied tyrosine hydroxylase (TH) gene variants in mood disorders using linkage disequilibrium techniques. One hundred and forty-five inpatients affected by bipolar (n = 88) and unipolar (n = 57) disorders, and 84 healthy controls, were typed for TH variants using polymerase chain reaction (PCR) amplification. TH was associated with mood disorder, with all affected subjects presenting an excess of TH*2 allele ( Tyrosine hydroxylase (TH) is the rate-limiting enzyme in the synthesis of dopamine and norephinephrine and has been proposed as a candidate for involvement in the development of psychiatric illness.
Tyrosine hydroxylase (TH) is the rate-limiting enzyme in the synthesis of dopamine and norephinephrine and has been proposed as a candidate for involvement in the development of psychiatric illness. 1, 2 The TH gene, located on the short arm of chromosome 11, has been the focus of considerable interest in studies on mood disorders following the initial report by Egland 3 indicating a significant linkage in the Old Order Amish multigenerational kindred. Despite intense efforts, however, no unequivocal findings have been forthcoming to date. Follow-up studies expanding and re-analyzing the same sample did not confirm the original finding, 4, 5 but positive results were reported in following years both with linkage and with association studies on independent samples (Table 1) .
TH gene transcription is under complex control. Its action is controlled by a DNA region located from −773 to +27 where, to various extents, multiple regions contribute to regulation of transcription. [6] [7] [8] [9] [10] [11] [12] At present, no definite information is available about which region might be the prime candidate for psychiatric association studies; in the present study we used a tetranucleotide polymorphism located in intron 1. 13 Association studies to compare allele and genotype frequency between affected and controls may have some limitations, as they do not take issues of population genetics into account, such as gene frequencies or disease prevalence. For these reasons, in our opinion, linkage disequilibrium techniques represent a more appropriate tool for the detection of gene-disease assocations. 14 In the present study, we investigate the potential association between TH gene and bipolar (BP) and unipolar (UP) disorders by applying techniques of population genetics. TH allele frequencies were significantly different from controls both for bipolar ( 2 = 15.81; d.f. = 4; P = 0.003), and unipolar ( 2 = 11.67; d.f. = 4; P = 0.019) subjects (Table 2) .
In particular, for bipolars TH*2 was in excess ( 2 = 8.69; d.f. = 1; P = 0.003; OR = 2.2; 95% CI = 1.29-3.71; AF 0.08) and TH*1 lacking ( 2 = 9.95; d.f. = 1; P = 0.002; OR = 0.46; 95% CI = 0.27-0.80; AF 0.10) compared to controls, while for unipolars the difference was due to an excess of both TH*2 and TH*3, although not to a significant level when considered separately vs all other alleles pooled, and a dearth of TH*1 ( 2 = 7.90; d.f. = 1; P = 0.005; OR = 0.45; 95% CI = 0.29-0.75; AF 0.13). Genotype analysis showed a significant dearth of TH*1/4 and TH*1/5 in UP vs controls (Table  3) . When we considered BP and UP pooled, we obtained a significant difference vs controls ( 2 = 18.34; d.f. = 4, P = 0.001) for allelic frequencies; post hoc analyses showed a TH*2 excess vs controls ( 2 = 8.30, d.f. = 1; P = 0.004) and lack of TH*1 ( 2 = 6.90, d.f. = 1, P = 0.009). To test the hypothesis that there is higher genetic loading on subgroups homogeneous for early age of onset or sex, we calculated frequencies in these subgroups. In early age of onset (Ͻ25 years; 25 BP, 11 UP), TH*2 was even more represented among bipolar subjects compared to controls ( 2 = 11.53; d.f. = 1; P = 0.0007), but this effect was not observed for unipolars. When considering sex subgroups, we did not detect significant differences. However subdividing subjects according to age of onset and sex yields to small sample sizes; the results should therefore be considered with caution. Both control subjects and patients were in Hardy-Weinberg equilibrium (BP P = 0.8, UP P = 0.65, controls P = 0.14).
EH showed a significant linkage disequilibrium in bipolars ( The results of the present study indicate a significant linkage disequilibrium of the TH gene with mood disorders. Bipolars showed an excess of TH*2, and both bipolar and unipolar subjects displayed a dearth of TH*1 when compared to controls; subgroups divided by sex did not significantly differ from the global sample but when divided according to early age of onset, the TH*2 excess among bipolars was more pronounced.
It is now commonly accepted as most probable that a single gene can only contribute a minor effect to the liability of developing psychiatric disorders and, fur- thermore, the exact transmission model is still unknown. 15 Association methods are suitable to investigate genes of minor effect in complex diseases where the exact transmission model is unknown, but they are exposed to many biases. [15] [16] [17] [18] [19] [20] It has been suggested that positive associations reported using markers that are not located in coding areas should be considered with caution. 21 However, TH gene transcription is under quite complex control and intronic sequences should not be excluded a priori from investigation, as they might play a role by themselves or by being in disequilibrium with control regions. [6] [7] [8] 10, 11 We used a tetranucleotide polymorphism located in intron 1. 13 In a part of the present sample we previously described an association between TH and bipolar disorder, mainly due to an excess of TH*2 in bipolars. 22 Moreover, a trend toward an association between TH*2 and mood disorders has recently been reported. 23 In our sample we observed a much stronger association in the early onset subgroup. Our observation is in accordance with current theories on complex traits that suggest a higher genetic loading in subjects that present an early onset of the disease. 15 The frequencies of alleles and genotypes in our sample are similar to those of previously published samples. Our control allele frequencies were close to the sample of Meloni, 24 Rietschel, 25 Cavazzoni 26 and Todd 27 (non-transmitted alleles) but different from the sample of Souery 23 (P = 0.018). Our bipolar sample showed allele frequencies similar to the sample of Souery, 23 Rietschel, 25 Meloni 24 and Cavazzoni 26 but different from the sample of Todd 27 (P = 0.03). Our unipolar sample was similar regarding allele frequencies to the sample of Souery. 23 In our bipolar sample, however, TH*2 was present with higher frequency compared to the published samples.
In our sample, TH variants conferred an odds ratio toward bipolar disorder of 2.2 (effect size w = 0.158). This level is above the lower threshold of detectable differences given our sample size (power = 0.8 for w = 0.15). Odds ratios relate to the risk of developing the disease given the risk factor, but the relevance of the risk factor is also related to its prevalence in the population. To address this issue it would be more adequate to consider the 'attributable fraction'. The attributable fraction is that part of subjects that would not present disease in the absence of the 'risk' factor. In our sample it ranged from 0.08 to 0.13. This means that, for example, in the absence of the risk allele TH*2 we would observe 8% less subjects presenting bipolar disorder.
The analysis of TH variants in our sample revealed a significant association with mood disorders and a linkage disequilibrium approach confirmed the association in both unipolar and bipolar samples. Discrepancies were, however, observed between EH and DIS-LAMB packages which were probably due to the different algorithms used: DISLAMB has greater power to detect disequilibrium with a low number of alleles and tends to be more conservative as the number of alleles increases. 28, 29 We observed this phenomenon in the unipolar sample, where positive results were obtained when pooling alleles reduced the allele number.
The TH gene has been extensively studied in mood disorders, and associations have been reported using various markers. However, many negative results have also been reported (Table 1) . A recent meta-analysis considering 11 studies (Taq 1 and tetranucleotide repeat only) excluded any involvement of TH in bipolar disorder, but issues like ethnic origin, disease severity or presence of family history of illness that could explain the heterogeneity of results could not be included in the analysis. 30 Moreover, it has been proposed that the TH locus may only influence suscepti-bility in a subset of families. 31 In a previous study, we investigated TH variants and psychopathology considering a subsample of the affected subjects (41 BP and 5 UP, 55). TH*2 proved to be associated with low depressive symptomatology among affected subjects independently of psychiatric diagnosis. However, given the small sample investigated, the hypothesis of a chance finding could be not ruled out. Taken together, TH reports suggest that it may be considered a 'small effect' gene in determining susceptibility to mood disorders, and that this may be true only for a subsample of all affective patients; however no exact definition of this subset has been proposed. 31 Our TH association with depressive symptomatology among affective patients supports the hypothesis that the clinical heterogeneity of psychiatric diagnoses may bias most association studies based on the diagnosis. 20, 32 As an example, an affective sample with a low rate of severely ill patients may obscure a true association. Polarity also may represent a stratification bias, in fact there is growing evidence from family studies supporting the differentiation between unipolar and bipolar I disorder. 33 A recent analysis differentiating unipolars and bipolars allowed the detection of an association that would have not been detected if only the whole sample had been considered. 23 Replications on clinically homogeneous samples using family-based association methods would be of particular value at this stage.
In conclusion, we reported a significant disequilibrium of the TH gene with both bipolar and unipolar disorders, a finding that is in accordance with previous positive reports.
Methods

Sample
Patients considered for this study were part of the sample collected for the European Collaborative Project on Affective Disorders. 34 We included 145 patients, (88 bipolar-BP; age: mean = 46.70 years, s.d. All patients received an extensive evaluation that included SADS 35 and/or DIS, 36 and were diagnosed according to DSM-IV 37 criteria by two psychiatrists, one of whom was a senior psychiatrist. Diagnostic criteria for inclusion in the study were clinical diagnoses of Mood Disorder: depressive disorder or recurrent and bipolar disorder. Dysthymia and cyclothymia were excluded, as were patients with diagnoses of mental retardation, drug dependence, or any physical or neurological illnesses that impaired psychiatric evaluation. All patients also underwent a detailed physical examination.
Control subjects were those individuals who came for blood testing at the HS Raffaele general laboratory, and were screened for the absence of any psychiatric disorder. All control subjects were given a general medical screening for major illnesses, and a brief psychiatric investigation from a senior psychiatrist to exclude any personal history of psychiatric disorders or the existence of psychiatric disorders in first-degree relatives. Italian geographic origin of controls was also required. From this pool of individuals, only those with adequate ethnic and clinical data were selected as controls, with a total of 84 subjects (age: mean = 46.79 years, s.d. = 15.74; m/f = 47/37).
DNA analysis
After informed consent was obtained, venous blood samples, anticoagulated with EDTA, were drawn from patients and controls. DNA was then extracted as described in Lahiri. 38 A polymerase chain reaction (PCR) was carried out with the following primers: 5Ј-CAGCTGCCCTAGTCAGCAG-3Ј and 5Ј-GCTTCCGAG TGCAGGTCACA-3Ј. One hundred nanograms of genomic DNA were diluted to 12.5 l using water and heated to 99°C for 3 min. Then a reaction mixture was added containing 1.5 U sample Taq Polymerase, 1× Taq Polymerase Buffer, 0.5 mM of each primer, 100 mM of dATP, dCTP, dTTP, dGTP in a total volume of 25 l; 10% of dCTP was labeled by P 33 . Thirty-five cycles were performed with a profile of 95°C for 20 s, 56°C for 20 s and 72°C for 20 s. This profile was followed by a 72°C chase for 4 min. Ten microliters of the denatured DNA were loaded per lane in 6.5% polyacrylamide gels. Electrophoresis was carried out at 12°C for 5 h at 60 W. Depending on the number of repeats present, alleles with a size of 260, 256, 252, 248 and 244 bp were produced (TH*1, TH*2, TH*3, TH*4 and TH*5).
Statistical analysis
Data were analyzed with Chi-square test to analyze the overall association; 2 × 2 tables composed by any (x) vs all other pooled (not-x) alleles or genotypes were used for post-hoc comparisons; odds ratios (OR) and attributable fractions (AF) were then calculated. We tested the power of our sample using allele frequencies ranging from 0.05 to 0.30 and odds ratio from 0.1 to 8.1 for each diagnosis, considering an alpha value of 0.05, two-tailed. As an example, for the bipolar sample we had enough power (0.80) to detect an effect size of 0.15 (OR = 2.15), corresponding to a risk allele with a frequency of 0.275 among patients and of 0.15 among controls. For the unipolar sample we could detect with a 0.80 power an effect size of 0.17 (OR = 2.31) and for the pooled sample we had enough power (0.80) to detect an effect size of 0.13 (OR = 1.94) which corresponds to a risk allele with a frequency of 0.25 among patients and of 0.15 among controls.
The study of disease-genotype association has recently been extended beyond classical chi-square tests by specific algorithms to derive haplotypes from association samples. EH 39 and DISLAMB 28 packages were used for the analysis of disequilibrium between TH and disease, with the specification of a disease allele frequency of 0.01 and dominant model of inheritance with non-carrier penetrance of 0.001 and carriers of 0.8 for bipolar disorder, and the same parameters except with a disease allele frequency of 0.05 for unipolar disorder.
